9 things to know about CT state troopers' fake ticket scheme.Dentist was ‘lying in wait’ for woman before murder-suicide, Wethersfield chief says.While Connecticut does not have any pending lawsuits against Endo related to its role in the opioid crisis, it is still participating in the settlement negotiations with the company. The settlement, which is contingent on final documentation and bankruptcy court approval, would require the $450 million to be paid in cash over 10 years to participating states and “subdivisions.” In addition to permanently banning Endo’s opioid marketing, it would mandate that the company turn over opioid-related documents for publication in an online archive and pay $2.75 million for archival expenses.Īsked about how much Connecticut might receive from the settlement, a spokesperson for Tong said that it was “too soon to say on state-specific amounts.”
The archive bridgeport full#
“By definitively addressing the more than $8 billion of debt that has burdened our balance sheet and establishing a pathway to closure with respect to the thousands of opioid-related and other lawsuits that the company has been defending at an unsustainable cost, we will be able to move forward as a new Endo and reach our full potential,” Endo Chief Executive Officer and President Blaise Coleman said in a statement. headquarters in Malvern, Pa., would facilitate the settlement.
The bankruptcy of Endo, an Ireland-based company with its U.S. “One by one, we are taking on every player in the addiction industry and holding them accountable for the lives they destroyed.” They downplayed risks, overpromoted benefits, and reaped profits while people suffered and died,” Tong said in a statement. “Endo falsely peddled its opioids as abuse-deterrent with deadly consequences. The deal resolves allegations that Endo increased sales using deceptive marketing that downplayed the risks of addiction and overstated the benefits of generic and branded opioids - drugs that include Percocet and Endocet, as well as Opana ER, which was withdrawn from the market in 2017. The agreement in principle with Endo, which filed for Chapter 11 bankruptcy on Tuesday, comprises the latest of several settlements involving Connecticut that aim to hold pharmaceutical companies accountable for their role in the national opioid crisis. Erik Trautmann / Hearst Connecticut MediaĬonnecticut is joining a $450 million nationwide settlement with opioid maker Endo International that would fund treatment and prevention programs, while it would also ban the company’s marketing of opioids and force the disclosure of millions of documents, state Attorney General William Tong announced Wednesday. Connecticut Attorney General William Tong has announced that Connecticut is joining a $450 million nationwide settlement with opioid maker Endo International that would fund treatment and prevention programs.
0 kommentar(er)
